CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-06-27 | AUSTIN STEPHEN G Director | Grant or award | +6,865 | 6,865 | ||
| 2013-06-27 | Abrams Jeffrey J Director | Grant or award | +6,865 | 45,927 | ||
| 2013-06-27 | Finnegan Paul Director | Grant or award | +6,865 | 6,865 | ||
| 2013-05-02 | BAUM MARK L Chief Executive Officer | Grant or award | +1,050,000 | 1,219,835 | ||
| 2013-05-02 | BAUM MARK L Chief Executive Officer | Grant or award | +200,000 | 1,419,835 | ||
| 2013-05-02 | BAUM MARK L Chief Executive Officer | Grant or award · Option - Right to Buy | +180,000 | 180,000 | ||
| 2013-04-01 | Schupp Joachim PH CHIEF MEDICAL OFFICER | Grant or award · OPTION RIGHT TO BUY | +25,000 | 25,000 | ||
| 2013-04-01 | Boll Andrew VP ACCOUNTING AND REPORTING | Grant or award · OPTION RIGHT TO BUY | +90,000 | 90,000 | ||
| 2012-12-14 | Bassani August Shelby Director | Grant or award · Option - Right to Buy | +38,014 | 38,014 | ||
| 2012-07-26 | AUSTIN STEPHEN G Director | Grant or award · Option - Right to Buy | +85,616 | 85,616 | ||
| 2012-07-18 | BAUM MARK L Chief Executive Officer | Grant or award | +800,000 | 1,646,927 | ||
| 2012-07-18 | Kammer Robert J Chairman of the Board | Grant or award | +200,000 | 4,634,254 | ||
| 2012-07-12 | DERMASTAR INTERNATIONAL, LLC 10% owner | Other disposition | −15,738,545 | 0 | ||
| 2012-07-12 | DERMASTAR INTERNATIONAL, LLC 10% owner | Conversion · Series A Convertible Preferred Stock | −10 | 0 | ||
| 2012-07-12 | DERMASTAR INTERNATIONAL, LLC 10% owner | Other disposition · Warrants (Right to Buy) | −241,308 | 0 | ||
| 2012-07-12 | BAUM MARK L Chief Executive Officer | Other acquisition | +846,927 | 846,927 | ||
| 2012-07-12 | BAUM MARK L Chief Executive Officer | Conversion · Series A Convertible Preferred Stock | −10 | 0 | ||
| 2012-07-12 | Kammer Robert J Chairman of the Board | Other acquisition | +4,434,254 | 4,434,254 | ||
| 2012-07-12 | Kammer Robert J Chairman of the Board | Conversion · Series A Convertible Preferred Stock | −10 | 0 | ||
| 2012-06-29 | DERMASTAR INTERNATIONAL, LLC 10% owner | Conversion | +7,498,500 | 15,738,545 |
Page 19 of 21 · 405 trades